Engineering UGT85A1 increases glycoside production in yeast, suggesting a method for sustainable biosynthesis.
Glycosides are diverse plant metabolites with important biological functions. Salidroside and its derivatives, natural phenylethanoid glycosides, have considerable potential in food and pharmaceutical applications, but their low natural abundance limits large-scale production. Microbial biosynthesis offers a sustainable alternative, where glycosyltransferase efficiency is critical. Here, we engineered UGT85A1 via iterative saturation mutagenesis (ISM), yielding the high-activity mutant DHG (G114D/F217H/C128G) with a 23.6-fold increase in catalytic efficiency. Molecular dynamics analyses indicated that DHG's enhanced activity stems from stabilized substrate binding and optimized catalytic geometry. In tyrosol- and hydroxytyrosol-overproducing yeast strains, DHG enabled salidroside and hydroxysalidroside production of 2.70 g/L (4.6×) and 1.63 g/L (19.4×), respectively─the highest titers reported in S. cerevisiae in shake-flask cultures (50 mL). This work provides a robust platform and general strategy for engineering plant UGTs to expand microbial production of high-value glycosides.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: